| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.37 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |